07 Jun2014

Pharmacyclics’ Leukemia Drug Beats Glaxo’s in Clinical Trial

Pharmacyclics Inc. (PCYC)’s Imbruvica, introduced this year for chronic lymphocytic leukemia, helped patients live longer without their disease worsening than GlaxoSmithKline Plc (GSK)’s treatment for the blood cancer.

17 May2014

Woman’s cancer killed by measles virus in unprecedented trial

Posted in Articles, News, World

Her name is Stacy Erholtz. For years, the 50-year-old mom from Pequot Lakes, Minn., battled myeloma, a blood cancer that affects bone marrow. She had few options left.

She had been through chemotherapy treatments and two stem cell transplants. But it wasn’t enough. Soon, scans showed she had tumors growing all over her body.

Live tweets

Twitter response: "Could not authenticate you."

Contact Us

Do you have any queries?

Quick Links

Ministry of Health Malaysia
National Committee for Clinical Research (NCCR)
Clinical Research Centre (CRC)
Economic Transformation Programme (ETP)
Medical Research Ethics Committee (MREC)

About | T&C | Organization | FAQ

Home
Services
- CRM CTA System
- CRM Study Coordinator’s Placements
ISR
Trial Sites
Big Data
Publications
Events
Media
FAQ
Contact Us
- Staff Directory